The 99th Annual Meeting of the Japanese Pharmacological Society
Advanced Search

Session Details

General oral sessinon一般演題 : 中枢神経(グリア細胞を含む）

[3-O]Oral Presentation

Wed. Mar 18, 2026 10:10 AM - 11:40 AM JST
Wed. Mar 18, 2026 1:10 AM - 2:40 AM UTC
Room 7(B203)
Chair:Norio Sakai(Grad Sch of Biomed Sci, Hiroshima Univ.), Eri Segi-Nishida(Tokyo University of Science)
10:10 AM - 10:25 AM JST(1:10 AM - 1:25 AM UTC)

[3-O-07]Role of the transcription factor CREB in antidepressant-like effects in the hippocampus

*Eri Segi-Nishida1, Yusuke Sumitomo1, Sayoko Yui1, Komachi Sasaki1, Naoto Sakai1, Yutaka Kanda1, Kanzo Suzuki1 (1. Tokyo University of Science)
Comment()
10:25 AM - 10:40 AM JST(1:25 AM - 1:40 AM UTC)

[3-O-08]Activity-dependent rapid induction of GPR3 and its CREB-dependent regulation of neuronal differentiation genes

*Shigeru Tanaka1, Fumiaki Ikawa1, Hiroko Shiraki1, Kana Harada1, Izumi Hide1, Norio Sakai1 (1. Graduate School of Biomedical and Health Sciences, Hiroshima University)
Comment()
10:40 AM - 10:55 AM JST(1:40 AM - 1:55 AM UTC)

[3-O-09]Brain-gut axis in mice treated with clarithromycin during early life: Involvement of the vagus nerve

*Ryota Araki1, Kano Ando1, Sakura Hirotani1, Yui Terashima1, Ayami Kita1, Takeshi Yabe1 (1. Setsunan University)
Comment()
10:55 AM - 11:10 AM JST(1:55 AM - 2:10 AM UTC)

[3-O-10]Activation of astrocytic TRPV4 by swelling and lipids.

*Koji Shibasaki1, Rimika Kabashima1, Amane Tateishi1 (1. University of Nagasaki)
Comment()
11:10 AM - 11:25 AM JST(2:10 AM - 2:25 AM UTC)

[3-O-11]Involvement of ventral hippocampal P2X7 receptors in anxiety-like behavior induced by acute restraint stress in mice.

*Takashi Iwai Iwai1, Misato Kanda1, Hayato Ohsumi1, Momoka Koyama1, Misa Oyama1, Shun Watanabe1, Mitsuo Tanabe1 (1. Laboratory of Pharmacology, school of Pharmacy, Kitasato university)
Comment()
11:25 AM - 11:40 AM JST(2:25 AM - 2:40 AM UTC)

[3-O-12]Enhancement of CaMKII/Rpt6 signaling inhibits alpha-synuclein accumulation Lewy body disease model mice

*Kohji Fukunaga1,2, Jing Xu2, Tomoki Sekimori2, Ichiro Kawahata3 (1. BRI Pharma Inc, 2. Tohoku University Pharmaceutical Science, 3. Fukushima Medical University)
Comment()
Back to Category List